T-cell expression of Bruton's tyrosine kinase promotes autoreactive T-cell activation and exacerbates aplastic anemia (Q92735508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

title

T-cell expression of Bruton's tyrosine kinase promotes autoreactive T-cell activation and exacerbates aplastic anemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

Simo Xia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Xiang Liu

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Xuetao Cao

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Sheng Xu

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

publication date

20 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Immunology

1 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

Targeting Bruton's tyrosine kinase in B cell malignancies

1 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Defective B cell development and function in Btk-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Bruton's tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

The Neutrophil Btk Signalosome Regulates Integrin Activation during Sterile Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Tyrosine kinase Btk is required for NK cell activation

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Phosphorylation-Mediated IFN-γR2 Membrane Translocation Is Required to Activate Macrophage Innate Response

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Advances in understanding the pathogenesis of acquired aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

A mouse model of lymphocyte infusion-induced bone marrow failure

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

1 reference

7 January 2021

Identification of novel regulators in T-cell differentiation of aplastic anemia patients

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Clinical management of aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Current concepts in the pathophysiology and treatment of aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Immune pathophysiology of aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Tec family kinases in T lymphocyte development and function

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk.

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

New insights into the regulation and functions of Tec family tyrosine kinases in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response.

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Comparing protein abundance and mRNA expression levels on a genomic scale

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

The cellular phenotype conditions Btk for cell survival or apoptosis signaling.

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Ibrutinib treatment improves T cell number and function in CLL patients

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Bruton's tyrosine kinase (BTK) as a promising target in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ

1 reference

https://api.crossref.org/works/10.1038%2FS41423-019-0270-9

7 January 2021

10.1038/S41423-019-0270-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31431692%20AND%20SRC:MED&resulttype=core&format=json